Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cerilliant
Cantor Fitzgerald
AstraZeneca
Novartis
Cipla
Daiichi Sankyo
Express Scripts
Moodys
Dow

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,074,668

« Back to Dashboard

Which drugs does patent 6,074,668 protect, and when does it expire?

Patent 6,074,668 protects ULTANE and is included in one NDA.

Protection for ULTANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-one patent family members in thirty-four countries.
Summary for Patent: 6,074,668
Title: Container for an inhalation anesthetic
Abstract:A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polyethylene napthalate. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
Inventor(s): Flament-Garcia; Mary Jane (Gurnee, IL), Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Garapolo; Joan (Libertyville, IL), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Ramsay; George M. (Waukegan, IL), Rice; Patrick (Waukegan, IL), Setesak; Jeffrey (Lincolnshire, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:09/004,876
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 6,074,668

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,074,668

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,083,514 Polymethylpentene container for an inhalation anesthetic ➤ Sign Up
6,162,443 Container for an inhalation anesthetic ➤ Sign Up
6,558,679 Container for an inhalation anesthetic ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,074,668

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey 200001695 ➤ Sign Up
Slovakia 285437 ➤ Sign Up
Slovakia 10462000 ➤ Sign Up
Slovenia 1045686 ➤ Sign Up
Russian Federation 2207105 ➤ Sign Up
Serbia 49636 ➤ Sign Up
Yugoslavia 40800 ➤ Sign Up
Portugal 1045686 ➤ Sign Up
Poland 193865 ➤ Sign Up
Poland 341735 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Cipla
Federal Trade Commission
Moodys
Colorcon
Mallinckrodt
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot